Target intelligence / Profile preview

Pulsed field ablation (PFA)

Target
PFA
Molecular classification
Other (energy-based ablation technology; not a biomolecule)
01

Overview

Pulsed field ablation (PFA) is a **nonthermal tissue ablation technique** that employs high-amplitude, short-duration pulsed electric fields to selectively destroy targeted cells and tissues via irreversible electroporation[1][3][6]. Unlike thermal methods (radiofrequency, cryoablation), PFA directly affects cell membranes, creating irreversible nanopores that disrupt cellular homeostasis, leading to cell death, while largely sparing the extracellular matrix and nearby non-target tissues[1][2][5]. PFA has gained prominence in cardiac electrophysiology for ablation of atrial fibrillation due to its rapid, efficient, and relatively safe tissue-selective effects[1][3][6]. It is also investigated for tumor ablation and tissue engineering, with growing evidence for its potential in scarless tissue regeneration[5][6]. PFA is not a drug target; it is a procedural technology whose effects depend on physical parameters rather than molecular interactions.

Other names
Pulsed electric field ablationIrreversible electroporation (when used for ablation)Nonthermal ablation via pulsed electric fieldsPEF ablationElectroporation ablation
02

Mechanism of action

High-voltage, rapidly pulsed electric fields create nanopores in cell membranes (electroporation) If the electric field is sufficiently strong, pores become irreversible, leading to loss of membrane integrity, apoptosis or necrosis Preferential ablation of certain cell types (e.g. cardiomyocytes) due to differential electroporation thresholds

03

Biological functions

Induces cell death (by irreversible electroporation)Ablation of pathological or targeted tissue (e.g. cardiac muscle for arrhythmias, tumor tissue, abnormal epithelium)Tissue selectivity—can spare extracellular matrix and non-target tissues
04

Disease associations

Cancer (tumor ablation)Cardiovascular disease (atrial fibrillation, arrhythmias)Other roles: regenerative medicine, tissue engineering, experimental wound healing
05

Safety considerations

Unintended ablation of non-target tissues (minimized compared to thermal methods)Neuromuscular excitation (pain, muscle contraction during procedure)Cardiac-specific: risk of arrhythmia, but reduced risk of collateral damage (esophagus, phrenic nerve, blood vessels) compared to thermal ablation

Beyond the preview

Go deeper on Pulsed field ablation (PFA).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pulsed field ablation (PFA).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call